Glatiramer acetate is an immunomodulatory peptide polymer used in the management of multiple sclerosis to reduce the frequency of relapses. As a complex mixture of synthetic polypeptides containing L-alanine,… Read more





Glatiramer acetate is an immunomodulatory peptide polymer used in the management of multiple sclerosis to reduce the frequency of relapses. As a complex mixture of synthetic polypeptides containing L-alanine, L-glutamic acid, L-lysine, and L-tyrosine, the rigorous analysis of this drug substance is critical for maintaining pharmaceutical consistency. This category provides high-quality reference standards, including the active ingredient, related impurity compounds such as 3-bromo-L-tyrosine, and stable isotope labelled versions. These materials are essential for pharmaceutical laboratories conducting comprehensive impurity profiling and method validation. By utilizing these precise analytical standards, researchers can ensure accurate identification and quantification of components throughout the manufacturing and quality control processes. These tools support the development of robust analytical methods required to confirm the identity, purity, and stability of this therapeutic agent.